Vo Thomas T. 4

What Happened

• Thomas T. Vo, Chairman and CEO of Nutex Health (NUTX), acquired 184,071 shares on April 9, 2026 via a private issuance (reported at $0.00 per share). He also converted/exercised a derivative on March 10, 2026 into 4,841 shares (reported at $0.00 per share). In total, 188,912 shares were acquired in these transactions; the filings show no cash consideration.

Key Details

• Transaction dates and codes:
  • 2026-03-10 — Exercise/conversion of derivative (Code M): 4,841 shares @ $0.00.
  • 2026-04-09 — Other acquisition (Code J): 184,071 shares @ $0.00.
• Total newly acquired: 188,912 shares; reported consideration $0.
• Shares are reported as held by Micro Hospital Holding LLC; Thomas Vo owns and controls that entity (Footnote F2).
• Footnote F1: The 184,071-share issuance represents two private issuances (95,076 and 88,995 shares) tied to the registrant’s one-time obligations related to two under‑construction hospitals transferred to Nutex Health Holdco LLC per prior merger agreements and disclosures.
• Footnote F3: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following an RSU grant previously reported (related to the March 10 transaction).
• Filing: Report filed April 10, 2026 covering transactions through April 9, 2026 (no late filing indicated).

Context

• Code M indicates conversion/exercise of a derivative (e.g., RSUs/options) into common shares; Code J denotes other acquisition (here, a private issuance under contractual obligations). Both transactions were issuances, not open‑market purchases or sales.
• Acquisitions reported at $0 often reflect contractual issuances or adjustments (for example, merger-related consideration or RSU vesting/conversion) rather than market purchases, and do not necessarily imply an outlay of cash by the insider.
• The securities are held through an entity controlled by Vo; reported activity updates beneficial ownership but does not alone indicate the insider’s market view.